<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Survival and response rates in <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> remain poor, despite advances in drug development </plain></SENT>
<SENT sid="1" pm="."><plain>There is increasing evidence to suggest that gender-specific differences may contribute to poor clinical outcome </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the hypothesis that genomic profiling of <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> is dependent on gender </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS &amp; METHODS: A total of 152 patients with <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> who were treated with <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> and continuous infusion <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> were genotyped for 21 polymorphisms in 13 cancer-related genes by PCR </plain></SENT>
<SENT sid="4" pm="."><plain>Classification and regression tree analysis tested for gender-related association of polymorphisms with overall survival, progression-free survival and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> response </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Classification and regression tree analysis of <z:hpo ids='HP_0000001'>all</z:hpo> polymorphisms, age and race resulted in gender-specific predictors of overall survival, progression-free survival and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> response </plain></SENT>
<SENT sid="6" pm="."><plain>Polymorphisms in the following genes were associated with gender-specific clinical outcome: <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor Î², EGF receptor, <z:e sem="disease" ids="C0043346" disease_type="Neoplastic Process" abbrv="">xeroderma pigmentosum</z:e> group D, voltage-gated <z:chebi fb="199" ids="26708">sodium</z:chebi> channel and phospholipase A2 </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Genetic profiling to predict the clinical outcome of patients with <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> may depend on gender </plain></SENT>
</text></document>